Nexus - 1301 - New Times Magazine-pages

Page Content (OCR)

CHRONIC SCURVY VITAMIN CAUSE DEFICIENCY AS A HEART DISEASE Heart disease, which is chronic scurvy in disguise, can be remedied with high doses of vitamin C together with the amino acid lysine, a therapy pioneered by Nobel Prize winning scientist Dr Linus Pauling but is a threat to the medical/ pharmaceutical establishment. he leading killer in the United States—the condition that those in medicine call “heart disease" or "occlusive cardiovascular disease"—is really a low-grade form of scurvy. This fact is becoming increasingly more difficult for modern medi- cine to deny. Heart disease is a misnomer. The disease is characterised by scab-like build-ups that slowly grow on the walls of blood vessels. The underlying disease process reduces the supply of blood to the heart and other organs, resulting in angina ("heart cramp"), heart attack and stroke. The correct terminology for this disease process is "chronic scurvy", a sub-clinical form of the classic vitamin C deficiency disease. The true nature of the disease was identified in the early 1950s by a Canadian team led by G. C. Willis, MD. This finding was confirmed in the late 1980s by the world's then leading scientist, Linus Pauling, PhD (1901-1994). Pauling alerted the world in lectures, in writing and on video after he and his associates conducted experiments that confirmed the Willis findings. To date, this alert has never made its way into a mainstream media outlet. Moreover, cardiologists are taught, and routinely tell their patients, that there is no connection between vitamin C and heart disease, and also that there is no value in vitamin C in amounts much higher than the minuscule RDA (recommended daily allowance). From a scientific standpoint, if a medical doctor or anyone tries to challenge the true nature of cardiovascular disease, they must be able to cite experiments that refute the Pauling/Willis chronic scurvy hypothesis. Such experiments have never been published. It's been 12 years since Pauling issued his final alert. Pharmacology professors Steve Hickey and Hilary Roberts, in their recent book Ascorbate: The Science of Vitamin C (2004), document that, incredibly, there have been no independent experiments published that were designed to test the Pauling hypothesis (except one at much lower doses that was conducted by Pauling's close associate Dr Matthias Rath). We are aware of only one clinical study in humans that has been carefully designed to test the Pauling high-dose hypothesis. The study was performed in the UK with 200 men over a period of three years (1997-2000), and the data confirmed Pauling's theory and therapy. Yet, so far, Dr Kale Kenton's study has not appeared in a medical journal. Will the giant pharmaceutical industry facing these facts survive or will it collapse in 2005? The end of the suppression of vitamin C will reveal the Codex Alimentarius restrictions for what they really are: a means to prop up an industry that has little reason to exist in its present form. The public is beginning to realise that the world's most prof- itable industry is really a house of cards. Its most profitable products are at best useless and at worst dangerous. Prescription drugs beget more drugs. The secret that dooms Big Pharma is that the best of health is achieved by taking high doses of vitamin C and avoid- ing toxic prescription medications as if your life depended on it. by Owen R. Fonorow, PhD, MS, MBA © 2005 PO Box 3097 Lisle, IL 60532, USA Email: owen@vitamincfoundation.org Website: http://www. VitaminCFoundation.org by Owen R. Fonorow, PhD, MS, MBA © 2005 History of the Great Suppression The 700,000 people who die needlessly every year in the USA are those who heed the advice of their cardiologist. The American Heart Association estimates that 63 million Americans suffer cardiovascular disease. More than one million undergo some form of heart operation, and over 15 million are taking statin cholesterol-lowering drugs on the advice of their doctor. These popular statin drugs are known to deplete CoQ10 (coenzyme Q10) and probably cause heart failure. The pioneering research into the relationship between vitamin C deficiency and heart disease began in the late 1940s, not long after the structure of vitamin C was determined. PO Box 3097 Lisle, IL 60532, USA NEXUS = 39 DECEMBER 2005 — JANUARY 2006 www.nexusmagazine.com